Pulmonary talcosis with intravenous drug abuse

Respiratory Care

Volumn 58, Issue 10, 2013, Pages

  Siddiqui, Mohammad F ^a   Saleem, Sabah ^b   Badireddi, Sridhar ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; CREATINE KINASE MB; OXYCODONE; TALC;

ACUTE RESPIRATORY FAILURE; ADULT; ARTICLE; ATELECTASIS; BRONCHOSCOPY; CASE REPORT; COMMUNITY ACQUIRED PNEUMONIA; COUGHING; DYSPNEA; FAINTNESS; FATIGUE; GIANT CELL; HUMAN; HUMAN TISSUE; HYPOXEMIA; IMMOBILITY; INTRAVENOUS DRUG ABUSE; LUNG DISEASE; MALE; PULMONARY TALCOSIS; RHABDOMYOLYSIS; SEIZURE; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; UNCONSCIOUSNESS;

ADULT; BIOPSY; BRONCHOSCOPY; DIAGNOSIS, DIFFERENTIAL; GRANULOMA, FOREIGN-BODY; HUMANS; LUNG DISEASES; MALE; SUBSTANCE ABUSE, INTRAVENOUS; TALC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84884604099     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.02402     Document Type: Article

References (15)

1. van Huisstede A, Noordhoek Hegt V, Otte-Holler I, Looijen-Salamon M, Rudolphus A. Talcosis due to abundant use of cosmetic talcum powder. Eur Respir Rev 2010;19(116):165-168.
2. Pairaudeau PW, Wilson RG, Hall MA, Milne M. Inhalation of baby powder: an unappreciated hazard. BMJ 1991;302(6786):1200-1201.
3. Dekel Y, Rath-Wolfson L, Rudniki C, Koren R. Talc inhalation is a life-threatening condition. Pathol Oncol Res 2004;10(4):231-233.
4. Egan AJ, Tazelaar HD, Myers JL, Abell-Aleff PC. Munchausen syndrome presenting as pulmonary talcosis. Arch Pathol Lab Med 1999;123(8):736-738.
5. Sieniewicz DJ, Nidecker AC. Conglomerate pulmonary disease: a form of talcosis in intravenous methadone abusers. AJR Am J Roentgenol 1980;135(4):697-702.
6. Ward S, Heyneman LE, Reittner P, Kazerooni EA, Godwin JD, Müller NL. Talcosis associated with IV abuse of oral medications: CT findings. AJR Am J Roentgenol 2000;174(3):789-793.
7. Cardillo G, Facciolo F, Carbone L, Regal M, Corzani F, Ricci A, et al. Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions. Eur J Cardiothorac Surg 2002; 21(2):302-305; discussion 305-306.
8. de Campos JR, Vargas FS, de Campos Werebe E, Cardoso P, Teixeira LR, Jatene FB, et al. Thoracoscopy talc poudrage: a 15-year experience. Chest 2001;119(3):801-806.
9. Marchiori E, Lourenco S, Gasparetto TD, Zanetti G, Mano CM, Nobre LF. Pulmonary talcosis: imaging findings. Lung 2010;188(2): 165-171.
10. Abraham JL, Brambilla C. Particle size for differentiation between inhalation and injection pulmonary talcosis. Environ Res 1980;21(1): 94-96.
11. Goldbach PD, Mohsenifar Z, Abraham JL, Young WI, Merrill WD. Talcum powder pneumoconiosis: diagnosis by transbronchial biopsy using energy-dispersive x-ray analysis. West J Med 1982;136(5): 439-442.
12. Roberts WC. Pulmonary talc granulomas, pulmonary fibrosis, and pulmonary hypertension resulting from intravenous injection of talccontaining drugs intended for oral use. Proc (Bayl Univ Med Cent) 2002;15(3):260-261.
13. Griffith CC, Raval JS, Nichols L. Intravascular talcosis due to intravenous drug use is an underrecognized cause of pulmonary hypertension. Pulm Med 2012;2012:617531.
14. Marchiori E, Souza Junior AS, Muller NL. Inhalational pulmonary talcosis: high-resolution CT findings in 3 patients. J Thorac Imaging 2004;19(1):41-44.
15. Shlomi D, Shitrit D, Bendayan D, Sahar G, Shechtman Y, Kramer MR. Successful lung transplantation for talcosis secondary to intravenous abuse of oral drug. Int J Chron Obstruct Pulmon Dis 2008; 3(2):327-330.